National Malaria Training Program
Training African Healthcare Workers in Malaria Prevention, Diagnosis and Treatment
Since 2006, Accordia and ExxonMobil have partnered to address the burden of malaria on the African continent. The Accordia-ExxonMobil partnership is characterized by a strong commitment to developing and rigorously evaluating innovative new approaches for improving the prevention, diagnosis and treatment of malaria. Through the partnership, Accordia and the Infectious Diseases Institute have developed programs that are highly responsive to local challenges and extremely effective in improving the prevention, diagnosis and treatment of malaria in Uganda, Nigeria and elsewhere in Africa.
In Uganda, the partners established the National Malaria Training Program, which has been endorsed by the Ugandan Ministry of Health and incorporated into Uganda’s effort to scale up malaria training activities at the national level. Clinicians are trained in the prevention, care and treatment of malaria, including the use of rapid diagnostic tests in place of standard-of-care presumptive treatment to reduce the unnecessary use of antimalarials. The program also provides training for pharmacists and the private sector, who supply the vast majority of antimalarials in Africa, and for community health workers in home-based management of fever.
Operational research to evaluate the clinical effectiveness and safety of the program found that the training significantly reduced the proportion of patients prescribed an antimalarial unnecessarily, improving long-term health outcomes, and resulted in substantial cost savings. With ExxonMobil’s support, Accordia is working to adapt the National Malaria Training Program for use in other African countries.